Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nobilon International BV

Division of Akzo Nobel NV

Latest From Nobilon International BV

Deals Shaping the Medical Industry (11/07)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

CoroNovative BV

CoroNovative BV is wagering that company co-founder Albert Osterhaus, PhD--who has a worldwide reputation as an expert on viruses--and the team assembling around him will make a habit of identifying new pathogens, and so provide the organization with intellectual property supportive of novel vaccines, diagnostics and treatments.
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Gastrointestinal
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Benelux
          • Netherlands
  • Parent & Subsidiaries
  • Akzo Nobel NV
  • Senior Management
  • Han van den Bosch, Dir., R&D
  • Contact Info
  • Nobilon International BV
    Phone: (31) 485 58 54 54
    Exportstraat 39B
    P.O. Box 320 AK Boxmeer , 5831